Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2005 Sep;81(959):580–585. doi: 10.1136/pgmj.2004.031633

Important cutaneous manifestations of inflammatory bowel disease

L Trost 1, J McDonnell 1
PMCID: PMC1743347  PMID: 16143688

Abstract

Inflammatory bowel disease (IBD) has many extraintestinal manifestations. Cutaneous manifestations are usually related to the activity of the bowel disease but may have an independent course. Anyone presenting with IBD should be examined for cutaneous manifestations. Pyoderma gangrenosum is a severe painful ulcerating disease that requires moist wound management and, in the absence of secondary infection, systemic corticosteroids, cyclosporine, or both. Infliximab may also be used. Erythema nodosum is a common cause of tender red nodules of the shins. Management includes leg elevation, NSAIDs, and potassium iodide. Oral manifestations of IBD include aphthous stomatitis, mucosal nodularity (cobblestoning), and pyostomatitis vegetans. Treatment should be directed both at the cutaneous lesions and at the underlying systemic condition.

Full Text

The Full Text of this article is available as a PDF (133.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apgar J. T. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review. Semin Dermatol. 1991 Sep;10(3):138–147. [PubMed] [Google Scholar]
  2. Bennett M. L., Jackson J. M., Jorizzo J. L., Fleischer A. B., Jr, White W. L., Callen J. P. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore) 2000 Jan;79(1):37–46. doi: 10.1097/00005792-200001000-00004. [DOI] [PubMed] [Google Scholar]
  3. Berkowitz E. Z., Lebwohl M. Cutaneous manifestations of inflammatory bowel disease. J Eur Acad Dermatol Venereol. 2000 Sep;14(5):349–350. doi: 10.1046/j.1468-3083.2000.00137.x. [DOI] [PubMed] [Google Scholar]
  4. Bijmer-Iest J. C., Rompelman-Schiere S. I., Van Ginkel C. J. Treatment of pyoderma gangrenosum with cyclosporin. Br J Dermatol. 1991 Sep;125(3):283–283. [PubMed] [Google Scholar]
  5. Boh Erin E., al-Smadi Raed Mahmoud Faleh. Cutaneous manifestations of gastrointestinal diseases. Dermatol Clin. 2002 Jul;20(3):533–546. doi: 10.1016/s0733-8635(02)00014-1. [DOI] [PubMed] [Google Scholar]
  6. Brinkmeier T., Frosch P. J. Pyodermatitis-pyostomatitis vegetans: a clinical course of two decades with response to cyclosporine and low-dose prednisolone. Acta Derm Venereol. 2001 May;81(2):134–136. doi: 10.1080/00015550152384290. [DOI] [PubMed] [Google Scholar]
  7. Brodell R. T., Mehrabi D. Underlying causes of erythema nodosum. Lesions may provide clue to systemic disease. Postgrad Med. 2000 Nov;108(6):147–149. doi: 10.3810/pgm.2000.11.1303. [DOI] [PubMed] [Google Scholar]
  8. Calobrisi S. D., Mutasim D. F., McDonald J. S. Pyostomatitis vegetans associated with ulcerative colitis. Temporary clearance with fluocinonide gel and complete remission after colectomy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Apr;79(4):452–454. doi: 10.1016/s1079-2104(05)80126-x. [DOI] [PubMed] [Google Scholar]
  9. Capella G. L., Frigerio E., Fracchiolla C., Altomare G. The simultaneous treatment of inflammatory bowel diseases and associated pyoderma gangrenosum with oral cyclosporin A. Scand J Gastroenterol. 1999 Feb;34(2):220–221. doi: 10.1080/00365529950173140. [DOI] [PubMed] [Google Scholar]
  10. Chaudhry S. I., Philpot N. S., Odell E. W., Challacombe S. J., Shirlaw P. J. Pyostomatitis vegetans associated with asymptomatic ulcerative colitis: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Mar;87(3):327–330. doi: 10.1016/s1079-2104(99)70217-9. [DOI] [PubMed] [Google Scholar]
  11. Chow R. K., Ho V. C. Treatment of pyoderma gangrenosum. J Am Acad Dermatol. 1996 Jun;34(6):1047–1060. doi: 10.1016/s0190-9622(96)90285-6. [DOI] [PubMed] [Google Scholar]
  12. Curley R. K., Macfarlane A. W., Vickers C. F. Pyoderma gangrenosum treated with cyclosporin A. Br J Dermatol. 1985 Nov;113(5):601–604. doi: 10.1111/j.1365-2133.1985.tb02385.x. [DOI] [PubMed] [Google Scholar]
  13. Danzi J. T. Extraintestinal manifestations of idiopathic inflammatory bowel disease. Arch Intern Med. 1988 Feb;148(2):297–302. [PubMed] [Google Scholar]
  14. Das K. M. Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis. Dig Dis Sci. 1999 Jan;44(1):1–13. doi: 10.1023/a:1026629528233. [DOI] [PubMed] [Google Scholar]
  15. Elizaga F. V. Erythema nodosum and indomethacin. Ann Intern Med. 1982 Mar;96(3):383–383. doi: 10.7326/0003-4819-96-3-383_2. [DOI] [PubMed] [Google Scholar]
  16. Fox M. D., Schwartz R. A. Erythema nodosum. Am Fam Physician. 1992 Sep;46(3):818–822. [PubMed] [Google Scholar]
  17. Goldstein F., Krain R., Thornton J. J. Intralesional steroid therapy of pyoderma gangrenosum. J Clin Gastroenterol. 1985 Dec;7(6):499–501. doi: 10.1097/00004836-198512000-00011. [DOI] [PubMed] [Google Scholar]
  18. González-Gay M. A., García-Porrúa C., Pujol R. M., Salvarani C. Erythema nodosum: a clinical approach. Clin Exp Rheumatol. 2001 Jul-Aug;19(4):365–368. [PubMed] [Google Scholar]
  19. Grange F., Djilali-Bouzina F., Weiss A. M., Polette A., Guillaume J. C. Corticosteroid-resistant pyoderma gangrenosum associated with Crohn's disease: rapid cure with infliximab. Dermatology. 2002;205(3):278–280. doi: 10.1159/000065860. [DOI] [PubMed] [Google Scholar]
  20. Greenstein A. J., Janowitz H. D., Sachar D. B. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976 Sep;55(5):401–412. doi: 10.1097/00005792-197609000-00004. [DOI] [PubMed] [Google Scholar]
  21. Gregory B., Ho V. C. Cutaneous manifestations of gastrointestinal disorders. Part II. J Am Acad Dermatol. 1992 Mar;26(3 Pt 2):371–383. doi: 10.1016/0190-9622(92)70059-o. [DOI] [PubMed] [Google Scholar]
  22. Halme L., Meurman J. H., Laine P., von Smitten K., Syrjänen S., Lindqvist C., Strand-Pettinen I. Oral findings in patients with active or inactive Crohn's disease. Oral Surg Oral Med Oral Pathol. 1993 Aug;76(2):175–181. doi: 10.1016/0030-4220(93)90200-n. [DOI] [PubMed] [Google Scholar]
  23. Helm T. N. Skin lesions: when to suspect systemic causes. Cleve Clin J Med. 1993 Mar-Apr;60(2):104–104. doi: 10.3949/ccjm.60.2.104. [DOI] [PubMed] [Google Scholar]
  24. Horio T., Danno K., Okamoto H., Miyachi Y., Imamura S. Potassium iodide in erythema nodosum and other erythematous dermatoses. J Am Acad Dermatol. 1983 Jul;9(1):77–81. doi: 10.1016/s0190-9622(83)70110-6. [DOI] [PubMed] [Google Scholar]
  25. Horio T., Imamura S., Danno K., Ofuji S. Potassium iodide in the treatment of erythema nodosum and nodular vasculitis. Arch Dermatol. 1981 Jan;117(1):29–31. [PubMed] [Google Scholar]
  26. Hughes A. P., Jackson J. M., Callen J. P. Clinical features and treatment of peristomal pyoderma gangrenosum. JAMA. 2000 Sep 27;284(12):1546–1548. doi: 10.1001/jama.284.12.1546. [DOI] [PubMed] [Google Scholar]
  27. Jennings J. L. Pyoderma gangrenosum: successful treatment with intralesional steroids. J Am Acad Dermatol. 1983 Oct;9(4):575–580. doi: 10.1016/s0190-9622(83)70172-6. [DOI] [PubMed] [Google Scholar]
  28. Lebwohl M., Lebwohl O. Cutaneous manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 1998 May;4(2):142–148. doi: 10.1002/ibd.3780040209. [DOI] [PubMed] [Google Scholar]
  29. Lehman C. W. Control of chronic erythema nodosum with naproxen. Cutis. 1980 Jul;26(1):66–67. [PubMed] [Google Scholar]
  30. Levitt M. D., Ritchie J. K., Lennard-Jones J. E., Phillips R. K. Pyoderma gangrenosum in inflammatory bowel disease. Br J Surg. 1991 Jun;78(6):676–678. doi: 10.1002/bjs.1800780613. [DOI] [PubMed] [Google Scholar]
  31. Lisciandrano D., Ranzi T., Carrassi A., Sardella A., Campanini M. C., Velio P., Bianchi P. A. Prevalence of oral lesions in inflammatory bowel disease. Am J Gastroenterol. 1996 Jan;91(1):7–10. [PubMed] [Google Scholar]
  32. Ljung T., Staun M., Grove O., Fausa O., Vatn M. H., Hellström P. M. Pyoderma gangrenosum associated with crohn disease: effect of TNF-alpha blockade with infliximab. Scand J Gastroenterol. 2002 Sep;37(9):1108–1110. doi: 10.1080/003655202320378338. [DOI] [PubMed] [Google Scholar]
  33. Loftus Edward V., Jr, Sandborn William J. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am. 2002 Mar;31(1):1–20. doi: 10.1016/s0889-8553(01)00002-4. [DOI] [PubMed] [Google Scholar]
  34. Lyon C. C., Smith A. J., Griffiths C. E., Beck M. H. Peristomal dermatoses: a novel indication for topical steroid lotions. J Am Acad Dermatol. 2000 Oct;43(4):679–682. doi: 10.1067/mjd.2000.106237. [DOI] [PubMed] [Google Scholar]
  35. Matis W. L., Ellis C. N., Griffiths C. E., Lazarus G. S. Treatment of pyoderma gangrenosum with cyclosporine. Arch Dermatol. 1992 Aug;128(8):1060–1064. [PubMed] [Google Scholar]
  36. McBride D. R. Management of aphthous ulcers. Am Fam Physician. 2000 Jul 1;62(1):149-54, 160. [PubMed] [Google Scholar]
  37. Mir-Madjlessi S. H., Taylor J. S., Farmer R. G. Clinical course and evolution of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: a study of 42 patients. Am J Gastroenterol. 1985 Aug;80(8):615–620. [PubMed] [Google Scholar]
  38. O'Donnell B., Powell F. C. Cyclosporine treatment of pyoderma gangrenosum. J Am Acad Dermatol. 1991 Jan;24(1):141–143. doi: 10.1016/s0190-9622(08)80051-5. [DOI] [PubMed] [Google Scholar]
  39. Penmetcha M., Navaratnam A. E. Pyoderma gangrenosum. Response to cyclosporin A. Int J Dermatol. 1988 May;27(4):253–253. doi: 10.1111/j.1365-4362.1988.tb03220.x. [DOI] [PubMed] [Google Scholar]
  40. Plauth M., Jenss H., Meyle J. Oral manifestations of Crohn's disease. An analysis of 79 cases. J Clin Gastroenterol. 1991 Feb;13(1):29–37. doi: 10.1097/00004836-199102000-00008. [DOI] [PubMed] [Google Scholar]
  41. Podolsky Daniel K. Inflammatory bowel disease. N Engl J Med. 2002 Aug 8;347(6):417–429. doi: 10.1056/NEJMra020831. [DOI] [PubMed] [Google Scholar]
  42. Powell F. C., Collins S. Pyoderma gangrenosum. Clin Dermatol. 2000 May-Jun;18(3):283–293. doi: 10.1016/s0738-081x(99)00119-4. [DOI] [PubMed] [Google Scholar]
  43. Powell F. C., Su W. P., Perry H. O. Pyoderma gangrenosum: classification and management. J Am Acad Dermatol. 1996 Mar;34(3):395–412. doi: 10.1016/s0190-9622(96)90428-4. [DOI] [PubMed] [Google Scholar]
  44. Powell Frank C., O'Kane Marina. Management of pyoderma gangrenosum. Dermatol Clin. 2002 Apr;20(2):347-55, viii. doi: 10.1016/s0733-8635(01)00029-8. [DOI] [PubMed] [Google Scholar]
  45. Requena Luis, Requena Celia. Erythema nodosum. Dermatol Online J. 2002 Jun;8(1):4–4. [PubMed] [Google Scholar]
  46. Schmitt E. C., Pigatto P. D., Boneschi V., Bubola D., Finzi A. F. Pyoderma gangrenosum treated with low-dose cyclosporin. Br J Dermatol. 1993 Feb;128(2):230–231. doi: 10.1111/j.1365-2133.1993.tb15162.x. [DOI] [PubMed] [Google Scholar]
  47. Schorr-Lesnick B., Brandt L. J. Selected rheumatologic and dermatologic manifestations of inflammatory bowel disease. Am J Gastroenterol. 1988 Mar;83(3):216–223. [PubMed] [Google Scholar]
  48. Schulz E. J., Whiting D. A. Treatment of erythema nodosum and nodular vasculitis with potassium iodide. Br J Dermatol. 1976 Jan;94(1):75–78. doi: 10.1111/j.1365-2133.1976.tb04345.x. [DOI] [PubMed] [Google Scholar]
  49. Schwaegerle S. M., Bergfeld W. F., Senitzer D., Tidrick R. T. Pyoderma gangrenosum: a review. J Am Acad Dermatol. 1988 Mar;18(3):559–568. doi: 10.1016/s0190-9622(88)70080-8. [DOI] [PubMed] [Google Scholar]
  50. Shashy R. G., Ridley M. B. Aphthous ulcers: a difficult clinical entity. Am J Otolaryngol. 2000 Nov-Dec;21(6):389–393. doi: 10.1053/ajot.2000.18872. [DOI] [PubMed] [Google Scholar]
  51. Soriano M. L., Martínez N., Grilli R., Fariña M. C., Martín L., Requena L. Pyodermatitis-pyostomatitis vegetans: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Mar;87(3):322–326. doi: 10.1016/s1079-2104(99)70216-7. [DOI] [PubMed] [Google Scholar]
  52. Storwick G. S., Prihoda M. B., Fulton R. J., Wood W. S. Pyodermatitis-pyostomatitis vegetans: a specific marker for inflammatory bowel disease. J Am Acad Dermatol. 1994 Aug;31(2 Pt 2):336–341. doi: 10.1016/s0190-9622(94)70167-9. [DOI] [PubMed] [Google Scholar]
  53. Tamir A., Landau M., Brenner S. Topical treatment with 1% sodium cromoglycate in pyoderma gangrenosum. Dermatology. 1996;192(3):252–254. doi: 10.1159/000246377. [DOI] [PubMed] [Google Scholar]
  54. Tan M. H., Gordon M., Lebwohl O., George J., Lebwohl M. G. Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody. Arch Dermatol. 2001 Jul;137(7):930–933. [PubMed] [Google Scholar]
  55. Triantafillidis J. K., Cheracakis P., Sklavaina M., Apostolopoulou K. Favorable response to infliximab treatment in a patient with active Crohn disease and pyoderma gangrenosum. Scand J Gastroenterol. 2002 Jul;37(7):863–865. [PubMed] [Google Scholar]
  56. Tutuncu Z., Morgan G. J., Jr, Kavanaugh A. Anti-TNF therapy for other inflammatory conditions. Clin Exp Rheumatol. 2002 Nov-Dec;20(6 Suppl 28):S146–S151. [PubMed] [Google Scholar]
  57. Ubogy Z., Persellin R. H. Suppression of erythema nodosum by indomethacin. Acta Derm Venereol. 1982;62(3):265–266. [PubMed] [Google Scholar]
  58. Veloso F. T., Carvalho J., Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol. 1996 Jul;23(1):29–34. doi: 10.1097/00004836-199607000-00009. [DOI] [PubMed] [Google Scholar]
  59. White J. W., Jr Erythema nodosum. Dermatol Clin. 1985 Jan;3(1):119–127. [PubMed] [Google Scholar]
  60. Williams A. J., Wray D., Ferguson A. The clinical entity of orofacial Crohn's disease. Q J Med. 1991 May;79(289):451–458. [PubMed] [Google Scholar]
  61. Wollina Uwe. Clinical management of pyoderma gangrenosum. Am J Clin Dermatol. 2002;3(3):149–158. doi: 10.2165/00128071-200203030-00002. [DOI] [PubMed] [Google Scholar]
  62. Zunt Susan L. Recurrent aphthous stomatitis. Dermatol Clin. 2003 Jan;21(1):33–39. doi: 10.1016/s0733-8635(02)00075-x. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES